Mahoney, Benjamin J and Morford, Kenneth L and Biegacki, Emma T and Tetrault, Jeanette M (2024) Hepatitis C virus and integrated care for substance use disorders. Clinical Liver Disease, 23, (1), e0241. DOI: 10.1097/CLD.0000000000000241.
External website: https://journals.lww.com/cld/fulltext/2024/01010/h...
Hepatitis C Virus (HCV) is a leading cause of liver disease morbidity and mortality. An estimated 58 million people worldwide are living with chronic HCV infection, with 1.5 million new infections annually.1 In the United States, ~3.2 million people are living with HCV, with 69,800 new infections in 2021 and a 129% increase in new acute cases between 2014 and 2021.2,3 New HCV infections in the United States are highest among men (65%), non-Hispanic American Indian/Alaskan Native people (66.9 per 100,000), and people 20–39 and 55–70 years of age.
G Health and disease > Substance use disorder (addiction)
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
J Health care, prevention, harm reduction and treatment > Health care delivery
VA Geographic area > United States
Repository Staff Only: item control page